APP and Alzheimer disease: The present study reports a number of protective effects of the loss of α4* nAChRs on the neuropathological alterations that develop over time in Tg2576 (APPswe) mice, a widely studied mouse model of AD that expresses a human APP transgene carrying the amyloidogenic Swedish mutation.